Patents by Inventor Famela Ramos

Famela Ramos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220160809
    Abstract: Disclosed are means, compounds, and compositions of matter useful for stimulation of natural killer cell activity. On one embodiment a composition termed QuadraMuneâ„¢ comprised of In some embodiments the invention teaches the administration of a therapeutic combination of ingredients comprising of metformin, pterostilbene, Nigella sativa, sulforaphane, and epigallocatechin-3-gallate (EGCG) to a mammal in need of natural killer cell immune modulation. In another embodiment, the invention teaches administration of said therapeutic combination to a mammal infected with said SARS-CoV-2. In some embodiments dosage of said therapeutic combination is based on inflammatory and/or immunological parameters observed in patients with COVID-19.
    Type: Application
    Filed: November 23, 2021
    Publication date: May 26, 2022
    Inventors: Thomas Ichim, Timothy G. Dixon, Famela Ramos, Wais Kaihani
  • Publication number: 20220125852
    Abstract: Disclosed are therapeutic compounds, protocols, and compositions of matter useful for treatment of neurological conditions. In one embodiment the invention teaches the treatment of chronic traumatic encephalopathy (CTE) through protecting/regenerating the endothelial by administration of cells such as stem cells. In one embodiment stem cells are administered in order to protect the endothelium from apoptosis and to preserve the blood brain barrier. In another embodiment stem cells are administered together with endothelial progenitor cells in order to regenerate neural endothelium. In other embodiments preservation of brain integrity in conditions of degeneration is accomplished by administration of stem cells and/or endothelial cells.
    Type: Application
    Filed: October 27, 2021
    Publication date: April 28, 2022
    Applicant: Therapeutic Solutions International, Inc.
    Inventors: Thomas E. Ichim, Timothy G. Dixon, Amit N. Patel, Famela Ramos, Kalina O'Connor
  • Publication number: 20220088086
    Abstract: Disclosed are means, methods and compositions of matter useful for reduction of brain inflammation and prevention of suicidal ideations and suicidal attempts. In one embodiment the invention provides utilization of autologous platelet rich plasma, alone, or admixed with regenerative/anti-inflammatory adjuvants, for reduction of neural inflammation. In one embodiment autologous PRP is admixed with oxytocin and administered intranasally in a patient at risk of suicidal ideation. In another embodiment, PRP is admixed with fortified and non-fortified nigella sativa oil and administered intranasally. Other embodiments include utilization of autologous stromal vascular fraction cells alone and/or admixed with regenerative/anti-inflammatory adjuvants.
    Type: Application
    Filed: September 24, 2020
    Publication date: March 24, 2022
    Applicant: Therapeutic Solutions International, Inc.
    Inventors: Thomas E. Ichim, Timothy G. Dixon, Famela Ramos, Kalina O'Connor
  • Publication number: 20220040248
    Abstract: Disclosed are means, methods, and therapeutic compositions for prevention of memory loss during situations of neuroinflammation. In one embodiment the invention teaches administration of the therapeutic combination of ingredients comprising of pterostilbene, Nigella sativa, sulforaphane, and epigallocatechin-3-gallate (EGCG) to a mammal suffering from inflammation in order to preserver memory function.
    Type: Application
    Filed: August 5, 2021
    Publication date: February 10, 2022
    Inventors: Thomas E. Ichim, Famela Ramos, James Veltmeyer, Timothy G. Dixon